+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Baxter International Inc (BAX) - Product Pipeline Analysis, 2020 Update

FEATURED COMPANIES

  • Becton Dickinson and Co
  • Boston Scientific Corp
  • Gel4Med Inc
  • Hospira Inc
  • Johnson & Johnson
  • Medtronic Plc
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Summary

Baxter International Inc (Baxter) is a provider of healthcare products, including dialysis in acute and chronic conditions, sterile intravenous solutions, parenteral nutrition therapies, generic injectable pharmaceuticals, infusion systems and devices, inhaled anesthetics, and surgical hemostat and sealant products. The company’s products find application in hospitals, kidney dialysis centers, rehabilitation centers, nursing homes and clinics, besides patients at home under physician supervision. Baxter distributes products through direct sales force and also through a network of independent distributors, drug wholesalers, specialty pharmacies and other alternative site providers. The company has operations in the Americas, the Middle East, Africa, Europe and Asia-Pacific. Baxter is headquartered in Deerfield, Illinois, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Baxter International Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Becton Dickinson and Co
  • Boston Scientific Corp
  • Gel4Med Inc
  • Hospira Inc
  • Johnson & Johnson
  • Medtronic Plc
  • MORE
Baxter International Inc Company Overview
  • Baxter International Inc Company Snapshot
  • Baxter International Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Baxter International Inc – Pipeline Analysis Overview
  • Business Description
  • Baxter International Inc - Key Facts
  • Baxter International Inc - Major Products and Services
  • Baxter International Inc Pipeline Products by Development Stage
  • Baxter International Inc Ongoing Clinical Trials by Trial Status
Baxter International Inc Pipeline Products Overview
  • AK98 Hemodialysis System
  • AK98 Hemodialysis System Product Overview
  • AK98 V3
  • AK98 V3 Product Overview
  • Arterial Everter
  • Arterial Everter Product Overview
  • Artis Dialysis System
  • Artis Dialysis System Product Overview
  • CAPD+
  • CAPD+ Product Overview
  • Celstat Topical Hemostatic Dressing
  • Celstat Topical Hemostatic Dressing Product Overview
  • CWP 800 Mini
  • CWP 800 Mini Product Overview
  • DurADAPT Bioimplant
  • DurADAPT Bioimplant Product Overview
  • ENFit Enteral Syringe
  • ENFit Enteral Syringe Product Overview
  • FloSeal Matrix Hemostatic Sealant
  • FloSeal Matrix Hemostatic Sealant Product Overview
  • FloSeal Matrix Hemostatic Sealant Clinical Trial
  • Hemopatch
  • Hemopatch Product Overview
  • Hemopatch Clinical Trial
  • Hemopatch - Dural Defects
  • Hemopatch - Dural Defects Product Overview
  • Infusion Pump
  • Infusion Pump Product Overview
  • Next Gen ICHD Monitor
  • Next Gen ICHD Monitor Product Overview
  • Non PVC CAPD
  • Non PVC CAPD Product Overview
  • Non-DEHP Sets
  • Non-DEHP Sets Product Overview
  • Olimel N12
  • Olimel N12 Product Overview
  • Ovart 3D Biodegradable Matrix
  • Ovart 3D Biodegradable Matrix Product Overview
  • oXiris
  • oXiris Product Overview
  • oXiris Clinical Trial
  • Peritoneal Dialysis Solution Generation System
  • Peritoneal Dialysis Solution Generation System Product Overview
  • Peritoneal Dialysis Solution Generation System Clinical Trial
  • PIVA Hemodynamic Monitoring System
  • PIVA Hemodynamic Monitoring System Product Overview
  • POC Generation 1 System
  • POC Generation 1 System Product Overview
  • POC Generation 2 System
  • POC Generation 2 System Product Overview
  • ProMaxx Microsphere
  • ProMaxx Microsphere Product Overview
  • Revaclear 500
  • Revaclear 500 Product Overview
  • Starling SV - Cardiac Risk Assessment
  • Starling SV - Cardiac Risk Assessment Product Overview
  • Synthetic Bone Graft - Spinal
  • Synthetic Bone Graft - Spinal Product Overview
  • Theranova 400 Dialyzer
  • Theranova 400 Dialyzer Product Overview
  • Theranova 400 Dialyzer Clinical Trial
  • Theranova 500 Dialyzer
  • Theranova 500 Dialyzer Product Overview
  • Theranova 500 Dialyzer Clinical Trial
  • TISSEEL
  • TISSEEL Product Overview
  • TISSEEL Clinical Trial
  • Tisseel Dura
  • Tisseel Dura Product Overview
  • URINFO 3000
  • URINFO 3000 Product Overview
  • Veritas - Cardiac Application
  • Veritas - Cardiac Application Product Overview
  • Baxter International Inc - Key Competitors
  • Baxter International Inc - Key Employees
  • Baxter International Inc - Key Employee Biographies
  • Baxter International Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Joint Venture
Recent Developments
  • Baxter International Inc, Recent Developments
  • Feb 27, 2020: Baxter launches Peri-Strips Dry with secure grip technology for reliable staple line reinforcement in surgical procedures
  • Jan 12, 2020: Baxter announces preliminary net sales for the fourth-quarter and full-year 2019 and announces preliminary full-year 2020 guidance
  • Jan 09, 2020: Pomerantz law firm investigates claims on behalf of investors of Baxter
  • Dec 02, 2019: Rosen, a highly ranked firm, announces filing of securities class action lawsuit against Baxter International
  • Nov 06, 2019: Baxter and Ayogo launch CKD&Me patient empowering digital education tool at Kidney Week 2019
  • Oct 24, 2019: Baxter reports preliminary third quarter 2019 operating results
  • Oct 23, 2019: Cheetah Medical presents correlation between Starling SV use and sepsis management at the CHEST Annual Meeting 2019 International Conference
  • Oct 14, 2019: Cheetah Medical to present at the CHEST annual meeting 2019 International Conference
  • Oct 10, 2019: Prismaflex haemofiltration systems installed with software versions 8.10, 7.20 and lower – risk of unexpected machine shutdown during treatment (MDA/2019/037)
  • Oct 01, 2019: Cheetah Medical Presents Update on FRESH Clinical Trial at the European Society of Intensive Care Medicine 32nd Annual Congress
Appendix
  • Methodology
  • About the Publisher
  • Contact
  • Disclaimer
List of Tables
  • Baxter International Inc Pipeline Products and Ongoing Clinical Trials Overview
  • Baxter International Inc Pipeline Products by Equipment Type
  • Baxter International Inc Pipeline Products by Indication
  • Baxter International Inc Ongoing Clinical Trials by Trial Status
  • Baxter International Inc, Key Facts
  • Baxter International Inc, Major Products and Services
  • Baxter International Inc Number of Pipeline Products by Development Stage
  • Baxter International Inc Pipeline Products Summary by Development Stage
  • Baxter International Inc Ongoing Clinical Trials by Trial Status
  • Baxter International Inc Ongoing Clinical Trials Summary
  • AK98 Hemodialysis System - Product Status
  • AK98 Hemodialysis System - Product Description
  • AK98 V3 - Product Status
  • AK98 V3 - Product Description
  • Arterial Everter - Product Status
  • Arterial Everter - Product Description
  • Artis Dialysis System - Product Status
  • Artis Dialysis System - Product Description
  • CAPD+ - Product Status
  • CAPD+ - Product Description
  • Celstat Topical Hemostatic Dressing - Product Status
  • Celstat Topical Hemostatic Dressing - Product Description
  • CWP 800 Mini - Product Status
  • CWP 800 Mini - Product Description
  • DurADAPT Bioimplant - Product Status
  • DurADAPT Bioimplant - Product Description
  • ENFit Enteral Syringe - Product Status
  • ENFit Enteral Syringe - Product Description
  • FloSeal Matrix Hemostatic Sealant - Product Status
  • FloSeal Matrix Hemostatic Sealant - Product Description
  • FloSeal Matrix Hemostatic Sealant - Blood-saving Effect of Combined Intravenous Tranexamic Acid with Topical Floseal Application, a Comparison with Intravenous Tranexamic Acid Only in Total Hip Arthroplasty
  • FloSeal Matrix Hemostatic Sealant - Efficacy of FloSeal in Endonasal Endoscopic Approach
  • FloSeal Matrix Hemostatic Sealant - Hemostatic Agent Use and Intraoperative Blood Loss in Lumbar Spine Surgery
  • FloSeal Matrix Hemostatic Sealant - Intraoperative Bleeding Control with Thrombin-Gelatin-Matrix (Floseal) in Advanced Gynecologic Surgery. A Case-control Study with Special Focus on Hemostasis in Patients with Primary or Secondary Coagulapathies
  • FloSeal Matrix Hemostatic Sealant - The Role of Floseal in the Prevention of Lymphocele and Lymphatic Ascites After Lymph Node Dissection for Gynecologic Cancer: a Randomized Controlled Trial
  • Hemopatch - Product Status
  • Hemopatch - Product Description
  • Hemopatch - A Prospective Randomized Trial of Hemopatch Versus No Hemopatch for the Intraoperative Hemostasis During Deceased Donor Renal Transplant
  • Hemopatch - A Single-arm Phase II Trial of Intra-operative Application of HEMOPATCH to the Pancreatic Stump to Prevent Post-operative Pancreatic Fistula Following Distal Pancreatectomy
  • Hemopatch - Assessment of the Usefulness of Hemopatch in Coronary Artery Bypass Graft Surgery
  • Hemopatch - Evaluating Hemopatch in Reducing Seroma Related Complications Following Axillary Lymph Node Dissection: a Pilot Study
  • Hemopatch - Exploratory Phase IV Randomized Single Blind Study Evaluating the Efficacy and Tolerability of Hemopatch in Improving Time of Hemostasis and Preventing Post-operative Complications after Hepatic Resection
  • Hemopatch - Hemopatch to Prevent Lymphatic Leak after Robotic Prostatectomy and Pelvic Lymph Node Dissection: A Randomized Controlled Trial
  • Hemopatch - Phase III, Randomized, Unblinded, Controlled Clinical Trial for Evaluating the Effectiveness of the Use of the New Hemostatic Patch Hemopatch in Patients Undergoing Surgical Liver Resection
  • Hemopatch - Prospective Pilot Study for the Efficacy and Security Analysis in the Protection of Ileocolic Anastomosis Conducted in Laparoscopic Right Hemicolectomy Because of Colon Cancer, Using a Using a NHS-PEG (N-hydroxysuccinimide Functionalized Polyethylene Glycol) Coated Collagen Patch
  • Hemopatch - Randomized Multicenter Controlled Study to Evaluate the Safety and Efficacy of HEMOPATCH Compared to Routine Care for Dural Clousure as Reinforcement for the Prevention of Postoperative Cerebrospinal Fluid Leakage (CSF) in Patients Undergoing Posterior Fossa Surgery
  • Hemopatch - Use of Hemopatch as a Sealant at the Pancreaticojejunostomy after Pancreatoduodenectomy to Prevent Postoperative Pancreatic Fistula
  • Hemopatch - Dural Defects - Product Status
  • Hemopatch - Dural Defects - Product Description
  • Infusion Pump - Product Status
  • Infusion Pump - Product Description
  • Next Gen ICHD Monitor - Product Status
  • Next Gen ICHD Monitor - Product Description
  • Non PVC CAPD - Product Status
  • Non PVC CAPD - Product Description
  • Non-DEHP Sets - Product Status
  • Non-DEHP Sets - Product Description
  • Olimel N12 - Product Status
  • Olimel N12 - Product Description
  • Ovart 3D Biodegradable Matrix - Product Status
  • Ovart 3D Biodegradable Matrix - Product Description
  • oXiris - Product Status
  • oXiris - Product Description
  • oXiris - A Multiple Center, Cohort Study of New Continuous Renal Replacement Therapy (CRRT) Membranes oXiris for Patients with Septic Shock
  • oXiris - A Pilot Multicentre Open-Label Randomized Controlled Trial During Treatment for Acute Kidney Injury in Critically Ill Patients with Septic Shock Comparing Two Haemofilter Membrane Devices, The An69st and the Newly Available Oxiris Haemofiltration Membrane for Early Resolution of Shock As Well As Other Clinical and Technical Performance Outcomes
  • oXiris - Antibiotic Plasma Concentrations During Continuous Renal Replacement Therapy with a High Adsorption Membrane (oXiris)
  • oXiris - Comparing Circuit Life between Modified AN69ST Membrane versus Standard Membrane Dialyser in Liver Failure Patients with Severe Acute Kidney Injury Study
  • oXiris - Development of a Web-based Multicenter Registry on the Use of oXiris Membrane for Extracorporeal Blood Purification Therapies in Critically Ill Patients
  • oXiris - Effect of Oxiris Membrane on Microcirculation Following Cardiac Surgery Under Cardiopulmonary Bypass: A Pilot Prospective Monocentric Study (Oxicard Study)
  • oXiris - Effects of Endotoxin Absorption and Cytokine Removal Hemofilter on Patients with Severe Septic Shock
  • oXiris - Increased Adsorption Membranes During Cardiopulmonary Bypass. A Randomized Controlled Trial to Evaluate Impact in Postsurgical Acute Kidney Injury
  • oXiris - The OXIRIS Filter in Septic Shock: The Adsorption of Endotoxin and Cytokines Improves the Haemodynamic, the Renal Function, and the Metabolic Response
  • Peritoneal Dialysis Solution Generation System - Product Status
  • Peritoneal Dialysis Solution Generation System - Product Description
  • Peritoneal Dialysis Solution Generation System - Improvement of Home Dialysis and to Simplify therapy Management Using On-demand Peritoneal Dialysis Solution System: US Clinical Study
  • PIVA Hemodynamic Monitoring System - Product Status
  • PIVA Hemodynamic Monitoring System - Product Description
  • POC Generation 1 System - Product Status
  • POC Generation 1 System - Product Description
  • POC Generation 2 System - Product Status
  • POC Generation 2 System - Product Description
  • ProMaxx Microsphere - Product Status
  • ProMaxx Microsphere - Product Description
  • Revaclear 500 - Product Status
  • Revaclear 500 - Product Description
  • Starling SV - Cardiac Risk Assessment - Product Status
  • Starling SV - Cardiac Risk Assessment - Product Description
  • Synthetic Bone Graft - Spinal - Product Status
  • Synthetic Bone Graft - Spinal - Product Description
  • Theranova 400 Dialyzer - Product Status
  • Theranova 400 Dialyzer - Product Description
  • Theranova 400 Dialyzer - A Multicentre, Open-label, Prospective, Randomized Study to Explore the Morbimortality in Patients Dialyzed with the Theranova HDx in Comparison to On-Line - Hemodiafiltration (Study MoTHER HDx)
  • Theranova 400 Dialyzer - A Randomized, Open-label, Cross Over Group, Single-centre Controlled Study To Evaluate The Clinical Performance Of Medium Cut-off Membrane Dialyzer Compared with High Flux Dialyzer in Removing Beta-2- Microglobulin Among Patients with End-stage Kidney Disease On Chronic Haemodialysis
  • Theranova 400 Dialyzer - Cardiovascular Risk Comparison Between Expanded Hemodialysis Using Theranova and On-line Hemodiafiltration - Exploratory, Multicenter, Randomized Clinical Trial
  • Theranova 400 Dialyzer - Characterization of Proteins and Forms of Albumin Removal Capacities of the Theranova Membrane by Innovating Proteomic Investigations
  • Theranova 400 Dialyzer - Effect of Hemodiafiltration Plus MCOs on Uremic Toxins Removal
  • Theranova 400 Dialyzer - Evaluation of Effectiveness, Safety and Health-related Quality of Life Associated with HDx Therapy Enabled by THERANOVA in Subjects with End-stage Renal Disease: A Colombian Study
  • Theranova 400 Dialyzer - Interventional Study to Assess the Effect of Extended Dialysis Using the Theranova Dialyzer on Patient Reported Symptoms Using the London Evaluation of Illness (LEVIL)
  • Theranova 400 Dialyzer - Medium-term Modulation of the Inflammatory Profile by Medium-cut Off Membranes in Patients with End Stage Renal Disease
  • Theranova 400 Dialyzer - Molecular and Cellular Mechanism of Vascular Ageing in Chronic Kidney Disease: Role of Theranova Dialyzer on Mineral Metabolism Disorder, Oxidative Stress, and Vascular Calcification
  • Theranova 400 Dialyzer - Multi-center, Prospective, Randomized Controlled Study in US to Evaluate the Effectiveness and Safety of THERANOVA
  • Theranova 400 Dialyzer - Randomized Controlled Trial of Theranova Versus High-flux Dialyzer on Preservation of Residual Renal Function in Incident Hemodialysis Patients
  • Theranova 400 Dialyzer - The Comparison of Expanded Dialysis with Theranova Dialyzer with Conventional High-flux Hemodialysis
  • Theranova 500 Dialyzer - Product Status 6
  • Theranova 500 Dialyzer - Product Description 6
  • Theranova 500 Dialyzer - A Multicentre, Open-label, Prospective, Randomized Study to Explore the Morbimortality in Patients Dialyzed with the Theranova HDx in Comparison to On-Line - Hemodiafiltration (Study MoTHER HDx)
  • Theranova 500 Dialyzer - An Open-label, Prospective, Randomized, Parallel-group, Exploratory Study to Explore the Safety and Efficacy of the HDx Therapy Using Theranova 500 Dialyzer in Comparison to Hemodiafiltration
  • Theranova 500 Dialyzer - Cardiovascular Risk Comparison Between Expanded Hemodialysis Using Theranova and On-line Hemodiafiltration - Exploratory, Multicenter, Randomized Clinical Trial
  • Theranova 500 Dialyzer - Characterization of Proteins and Forms of Albumin Removal Capacities of the Theranova Membrane by Innovating Proteomic Investigations
  • Theranova 500 Dialyzer - Interventional Study to Assess the Effect of Extended Dialysis Using the Theranova Dialyzer on Patient Reported Symptoms Using the London Evaluation of Illness (LEVIL)
  • Theranova 500 Dialyzer - Medium-term Modulation of the Inflammatory Profile by Medium-cut Off Membranes in Patients with End Stage Renal Disease
  • Theranova 500 Dialyzer - Molecular and Cellular Mechanism of Vascular Ageing in Chronic Kidney Disease: Role of Theranova Dialyzer on Mineral Metabolism Disorder, Oxidative Stress, and Vascular Calcification
  • Theranova 500 Dialyzer - The Comparison of Expanded Dialysis with Theranova Dialyzer with Conventional High-flux Hemodialysis
  • TISSEEL - Product Status
  • TISSEEL - Product Description
  • TISSEEL - Modified Muller's Muscle-conjunctival Resection Internal Ptosis Repair Using Fibrin Glue
  • TISSEEL - The Use of Fibrin Glue Sealant (Tisseel) as a Reinforcement of Esophagojejunal Anastomoses will Decrease the Rate of Anastomotic Leak
  • Tisseel Dura - Product Status
  • Tisseel Dura - Product Description
  • URINFO 3000 - Product Status
  • URINFO 3000 - Product Description
  • Veritas - Cardiac Application - Product Status
  • Veritas - Cardiac Application - Product Description
  • Baxter International Inc, Key Employees 6
  • Baxter International Inc, Key Employee Biographies
  • Baxter International Inc, Subsidiaries
  • Baxter International Inc, Joint Venture
  • Glossary
List of Figures
  • Baxter International Inc Pipeline Products by Equipment Type
  • Baxter International Inc Pipeline Products by Development Stage
  • Baxter International Inc Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
  • Medtronic Plc
  • Gel4Med Inc
  • Hospira Inc
  • NxStage Medical Inc
  • Johnson & Johnson
  • Becton Dickinson and Co
  • Boston Scientific Corp
  • Fresenius Medical Care AG & Co KGaA
Note: Product cover images may vary from those shown
Adroll
adroll